myopia
Conditions
Interventions
Tear film management team:using tear secreting agents, with a daily eye drop frequency of 6 times
Non tear film management group:No medication
Sponsors
Shanghai Bright Eye Hospital
Eligibility
Sex/Gender
All
Age
8 Years to 18 Years
Inclusion criteria
Inclusion criteria: 1. Gender: Both genders are acceptable 2. Age: 8-18 years old 3. Patients who plan to wear or wear corneal shaping lenses 4. Not using drugs such as atropine or artificial tears with low concentrations within one month 5. Myopia diopter range -1.0D~-6.0D 6. Both eyes are normal except for distant/nearsighted eyes. Definition of normal eyes: No history of eye injury or surgery No eyelid abnormalities or infections No conjunctival abnormalities or history of moderate to severe conjunctivitis or keratitis No clinically significant slit lamp examination findings (such as edema, staining, scars, neovascularization, exudation or abnormal turbidity) No trichiasis or entropion No other active eye diseases 7. Those who can complete at least 3 months of follow-up and wear OK glasses and use dexamethasone sodium according to the protocol requirements 8. Able to understand the purpose of the experiment, voluntarily participate and have the subject or their legal guardian sign an informed consent form
Exclusion criteria
Exclusion criteria: 1. People with local or systemic diseases that may affect the wearing of OK glasses, such as acute and chronic sinusitis, hyperthyroidism, severe diabetes, rheumatoid arthritis and other collagen diseases, mental diseases, excessive nervousness, etc 2. Abnormalities in fundus examination, such as retinal detachment, macular edema, increased cup to disc ratio, etc 3. Individuals who are allergic to any component in the research product 4. Patients who have been exposed to special environments such as dryness, severe dust, or volatile chemicals for a long time 5. Those who are using any systemic medication or any eye medication that is contraindicated for wearing OK lenses 6. Participants in clinical trials of other drugs or medical devices within 30 days prior to screening 7. Other situations where the researcher determines that wearing OK glasses is not suitable or cannot be selected
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BUT; | — |
Secondary
| Measure | Time frame |
|---|---|
| Corneal fluorescein staining score; | — |
Countries
China
Contacts
Public ContactYuJiao Zhang
Shanghai Bright Eye Hospital
Outcome results
None listed